BRÈVE publiée le 22/01/2026 à 15:00, il y a 3 heures 48 minutes Sparton Resources Inc. Secures Approval for Private Placement Private Placement Regulatory Approval Flow-through Shares Resource Exploration Sparton Resources
BRÈVE publiée le 22/01/2026 à 15:00, il y a 3 heures 48 minutes Sparton Resources Inc. obtient l'approbation pour un placement privé Placement Privé Actions Accréditives Exploration Des Ressources Approbation Réglementaire Ressources Sparton
COMMUNIQUÉ DE PRESSE publié le 22/01/2026 à 14:55, il y a 3 heures 53 minutes Sparton Resources Inc. Final Approval for Private Placement and Updates Sparton Resources Inc. receives final approval for C$410,000 private placement offering for resource exploration. Proceeds to fund Critical Metals projects in Ontario and Quebec Private Placement Resource Exploration Critical Metals Projects Sparton Resources Inc. Ontario And Quebec
Publié le 22/01/2026 à 18:37, il y a 11 minutes Kootenay Silver Announces Upsize of Bought Deal LIFE Private Placement to Gross Proceeds of C$16.5 Million
Publié le 22/01/2026 à 15:50, il y a 2 heures 58 minutes Premier American Uranium Announces Upsize of Bought Deal Private Placement to C$13 Million
Publié le 22/01/2026 à 15:00, il y a 3 heures 48 minutes Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
Publié le 22/01/2026 à 14:55, il y a 3 heures 53 minutes Sparton Resources Inc. Final Approval for Private Placement and Updates
Publié le 22/01/2026 à 18:37, il y a 10 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 22/01/2026 à 18:24, il y a 24 minutes Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Publié le 22/01/2026 à 18:21, il y a 27 minutes Turkiye Garanti Bankasi A.S.: Redemption of the debt instrument at abroad within the Medium Term Note (MTN) program
Publié le 22/01/2026 à 18:00, il y a 48 minutes BIOSYNEX SA: CHEMBIO DIAGNOSTIC SYSTEMS INC., FILIALE DE BIOSYNEX, ANNONCE LE DOUBLE DÉPÔT À LA FDA DU TEST DPP® SYPHILIS TnT SUITE À LA DÉSIGNATION DE DISPOSITIF INNOVANT (BREAKTHROUGH DEVICE)
